Show simple item record

Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies

dc.contributor.authorZeng, Gen_US
dc.contributor.authorKoffas, Aen_US
dc.contributor.authorMak, L-Yen_US
dc.contributor.authorGill, USen_US
dc.contributor.authorKennedy, PTFen_US
dc.date.accessioned2023-05-24T14:00:18Z
dc.date.available2023-02-06en_US
dc.date.issued2023en_US
dc.identifier.otherARTN 100720en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/88201
dc.relation.ispartofJHEP REPORTSen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectHepatitis B virusen_US
dc.subjectAntiviral agentsen_US
dc.subjectBiomarkersen_US
dc.subjectImmune reconstitutionen_US
dc.titleUtility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studiesen_US
dc.typeArticle
dc.identifier.doi10.1016/j.jhepr.2023.100720en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001043944700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue6en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume5en_US


Files in this item

Thumbnail
Name:
Kennedy Utility of novel viral ...
Size:
1.206Mb
Format:
application/
Description:
Published version
View/Open
Thumbnail
Name:
license_rdf
Size:
811bytes
Format:
application/rdf+xml
View/Open

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States